Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows: - sale of consumables (52.8%); - sale of equipment (28.8%); - provision of after-sales services (18.4%). The vast majority of net sales are earned abroad.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

14/10 Earnings release - Q2 2026

More about the company

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Market Closed - OTC Markets Other stock markets 12:17:35 09/04/2026 am IST			5-day change	1st Jan Change
0.5320 ^USD	+66.25%		-.--%	+66.25%

24/07	Theraclion SA Reports Consolidated Revenue Results for the First Half Ended June 30, 2026	CI
09/07	Theraclion Announces Board Changes	CI

Market Cap	4.42Cr 5.09Cr 4.13Cr 3.78Cr 7.14Cr 484.72Cr 7.23Cr 48Cr 19Cr 242.18Cr 19Cr 19Cr 806.08Cr	P/E 2024	-2.66x	P/E 2025	-6.33x
Enterprise Value	5.2Cr 5.99Cr 4.87Cr 4.45Cr 8.41Cr 570.91Cr 8.52Cr 57Cr 22Cr 285.25Cr 23Cr 22Cr 949.42Cr	EV / Sales 2024	22.5x	EV / Sales 2025	55.4x
Free-Float	54.37%	Yield 2024 *	-	Yield 2025	-

24/07	Theraclion SA Reports Consolidated Revenue Results for the First Half Ended June 30, 2026	CI
09/07	Theraclion Announces Board Changes	CI
09/07	Theraclion Appoints New Chairman	MT
19/06	Claude Lenoir appointed interim chairman of Theraclion
19/06	Theraclion Chairman Steps Down; Interim Successor Named	MT
18/06	Theraclion Announces Board Changes	CI
09/06	Theraclion Secures AMA CPT Editorial Panel Approval For New Category III CPT Code For Sonovein	CI
05/06	Theraclion deploys first Sonovein system in China
05/06	Theraclion JV Deploys Sonovein System at Chinese Hospital	MT
05/06	Theraclion Announces First Clinical Deployment Of Sonovein In Hainan, China	CI
05/06	Theraclion Deploys Sonovein System At Boao Super Hospital in Hainan Province	CI
01/06	Theraclion Presents Promising Preliminary Results From Sonovein SpeedPulse At First International HIFU Congress	CI
11/05	Bouygues, Euronext, Vallourec... stocks to watch today in Paris

23/07	Theraclion Initiates Its Commercial Momentum in the First Half of 2026	BU
15/07	Theraclion: First Half 2026 Report on the Liquidity Contract With CRÉDIT INDUSTRIEL ET COMMERCIAL	BU
09/07	Theraclion Strengthens Its Governance by Appointing Vincent Gardès as Chairman of Its Board of Directors	BU
18/06	Theraclion Announces the Evolution of Its Board of Directors	BU
08/06	Theraclion Secures Key U.S. Reimbursement Milestone for Sonovein® With AMA CPT Editorial Panel Approval of a New Category III CPT Code	BU

Theraclion Share Price OTC Markets

Stocks

TCLI.F

FR0010120402

Advanced Medical Equipment & Technology

Valuation: Theraclion

Chart: Theraclion

Latest news : Theraclion

Press Releases: Theraclion

News in other languages: Theraclion

Quotes and Performance

Course Extremes

Managers and Directors: Theraclion

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Income Statement and Estimates

Annual profits - Rate of surprise

23/07	THERACLION AMORCE SA DYNAMIQUE COMMERCIALE AU PREMIER SEMESTRE 2026
15/07	Theraclion: BILAN DU PREMIER SEMESTRE 2026 DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC LE CRÉDIT INDUSTRIEL ET COMMERCIAL
09/07	Vincent Gardès prend la présidence du conseil d'administration de Theraclion
09/07	THERACLION RENFORCE SA GOUVERNANCE EN NOMMANT VINCENT GARDÈS À LA PRÉSIDENCE DE SON CONSEIL D'ADMINISTRATION
19/06	Bourse : Crédit Agricole veut jouer un rôle en Italie, 2CRSi va communiquer

Current year	0.53	0.53
1 year	0.53	0.53
3 years	0	0.59
5 years	0	2.28
10 years	0	2.6

Manager	Title	Age	Since
Martin Deterre CEO	Chief Executive Officer	-	24/05/2023
Julie Veisseire DFI	Director of Finance/CFO	-	-
Alexandra Rocher COO	Chief Operating Officer	-	-

Director	Title	Age	Since
Renaud Saleur BRD	Director/Board Member	-	01/02/2018
Ari Kellen BRD	Director/Board Member	-	13/02/2019
Shawn Langer BRD	Director/Board Member	-	13/02/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THERACLION	+66.25%	-.--%	-	-	5.15Cr
THERMO FISHER SCIENTIFIC, INC.	+0.38%	+0.56%	+29.20%	+5.72%	21TCr
DANAHER CORPORATION	+0.16%	+1.94%	+2.46%	-21.50%	14TCr
INTUITIVE SURGICAL, INC.	-0.40%	+5.88%	-21.17%	+20.82%	13TCr
BOSTON SCIENTIFIC CORPORATION	+3.27%	+7.17%	-52.11%	-2.80%	6.92TCr
EDWARDS LIFESCIENCES CORPORATION	+0.39%	+2.76%	+13.62%	+12.28%	5.13TCr
SIEMENS HEALTHINEERS AG	-0.36%	+4.16%	-14.57%	-20.67%	5.04TCr
AGILENT TECHNOLOGIES, INC.	+0.16%	+1.90%	+24.83%	+11.91%	3.99TCr
WATERS CORPORATION	-0.08%	+5.10%	+43.92%	+37.88%	3.93TCr
RESMED, INC.	-0.35%	+7.04%	-20.40%	+24.54%	3.23TCr
Average	+6.94%	+4.27%	+0.64%	+7.58%	8.54TCr
Weighted average by Cap.	+0.36%	+3.41%	+2.85%	+4.05%

	2024	2025
Net sales	8L 10L 8L 7L 13.42L 9.11Cr 13.6L 90.95L 35.69L 4.55Cr 35.92L 35.14L 15Cr	7L 8L 6L 6L 10.54L 7.16Cr 10.68L 71.42L 28.03L 3.58Cr 28.21L 27.6L 12Cr
Net income	-57.57L -66.34L -53.91L -49.31L -93.1L -63Cr -94.31L -6.31Cr -2.48Cr -32Cr -2.49Cr -2.44Cr -105.09Cr	-56.9L -65.57L -53.28L -48.74L -92.01L -62Cr -93.21L -6.23Cr -2.45Cr -31Cr -2.46Cr -2.41Cr -103.87Cr
Net Debt	34.11L 39.3L 31.94L 29.21L 55.15L 37Cr 55.87L 3.74Cr 1.47Cr 19Cr 1.48Cr 1.44Cr 62Cr	78.52L 90.48L 73.52L 67.26L 1.27Cr 86Cr 1.29Cr 8.6Cr 3.38Cr 43Cr 3.4Cr 3.32Cr 143.34Cr